Questions to Solicit Stakeholder Feedback on Data & Analytics to Support Health System Transformation
Freedman HealthCare, on behalf of the Vermont Agency of Human Services, Office of Health Care Reform
All Questions are optional. Please feel free to focus on the areas most relevant to you.
Name (Optional)
First Name
Last Name
Organization (Optional)
Practice location:
Northern
Central
Southern
Respondent type:
Clinician
Manager/Administrator
Clinician/Manager
Other
Practice type:
Hospital
Hospital-primary care
Federally Qualified Health Center (FQHC)
Independent provider office - Primary care
Independent provider office - Specialty care
1. Are you a current or former provider participant in a fee-for-service alternative or value-based payment model? (Select all that apply)
The All-Payer Accountable Care Organization Model with OneCare Vermont
OneCare Vermont’s ComprehensivePayment Reform for Primary Care
The Blueprint for Health
Blue Cross and Blue Shield ofVermont’s Enhanced Community Primary Care Program
Blue Cross and Blue Shield Vermont BlueIntegrated Care
Other
2A. If you are or have been a value-based payment model participant what kind of data or analytics have you received to support care transformation and efficiency? (Select all that apply)
Clinical data
Claims-based data
Tailored analyses for population health management (Example: lists of patients due for routine screenings, annual wellness visits, medication reconciliation, etc.)
Patient risk stratification
Quality metric performance monitoring
Analyses of opportunities for care pathway redesign to promote efficiency
Tailored analyses of service utilization and intensity
Other
2B. If you would like to elaborate on your response to question 2A, please do so here.
3A. When you received/receive data and analyses to support transformation, how frequently was/is the information provided to you? (Please include frequency for all data types received.)
3B. What is the ideal frequency for data and analytics to support system transformation? (Please include ideal frequency for financial data, quality tracking data, and clinical data.)
4A. When you received/receive data and analyses to support transformation, are data at the patient-level, panel-level, or other?
Data at the patient-level
Panel-level
Other
4B. What level of data (patient-level, panel-level, or other) are required to optimally inform quality improvement and cost management?
5A. When you received/receive data and analyses to support transformation how would you characterize it?
Actionable
Relevant
Irrelevant
Burdensome
Other
5B. If you would like to elaborate on your response to question 5A, please do so here.
6A. Have data and analyses been useful in your practice or in your management of a health care facility? Which analytical products are most useful for panel management, quality improvement, for managing cost targets, or for improving experience-of-care?
6B. Have you received data, analytics, or reports from multiple sources?
Yes
No
6C. If you received data from multiple sources, was it helpful, confusing, contradictory or superfluous?
7A. Were there any barriers, such as inadequate number of staff or available staff time, to using the data you received or limitations to the usefulness of the data?
7B. Were/are data and analyses accompanied by technical assistance or quality improvement support?
7C. When technical assistance is available, how would you characterize its usefulness? Examples could include: actionable, relevant, irrelevant, or burdensome.
8. Did/do you receive data about patient experience of care that was relative to the goals of value-based payment models, such as increasing access to care?
9. Please share any other considerations for optimizing data and analytics to support health system transformation (EMR capabilities, financial barriers to acquiring software or other technology for utilizing the data, etc...)
Submit
Should be Empty: